BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 175 filers reported holding BIOLIFE SOLUTIONS INC in Q3 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $277,974 | -87.3% | 12,578 | -87.5% | 0.00% | -90.9% |
Q1 2023 | $2,191,008 | +57.0% | 100,736 | +31.4% | 0.01% | +37.5% |
Q4 2022 | $1,395,139 | +405.5% | 76,656 | +532.5% | 0.01% | +700.0% |
Q3 2022 | $276,000 | -27.7% | 12,119 | -8.1% | 0.00% | -66.7% |
Q3 2020 | $382,000 | – | 13,194 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 7,721,535 | $170,645,924 | 14.91% |
Gagnon Advisors, LLC | 360,758 | $7,972,751 | 5.34% |
Park West Asset Management LLC | 2,081,083 | $45,991,934 | 4.02% |
Meros Investment Management, LP | 324,479 | $7,170,986 | 3.56% |
GAGNON SECURITIES LLC | 637,576 | $14,090,429 | 2.93% |
Mesirow Financial Investment Management, Inc. | 16,947 | $374,529 | 1.59% |
Zweig-DiMenna Associates LLC | 256,000 | $5,657,600 | 0.71% |
GENEVA CAPITAL MANAGEMENT LLC | 1,561,443 | $34,507,882 | 0.68% |
PALISADE CAPITAL MANAGEMENT, LP | 1,134,352 | $25,069,179 | 0.67% |
Penbrook Management LLC | 41,500 | $917,150 | 0.66% |